Welcome to LookChem.com Sign In|Join Free
  • or
Pyridine, 3-(chloromethyl)-2-methyl-6-[4-(trifluoromethyl)phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

851069-89-1

Post Buying Request

851069-89-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851069-89-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851069-89-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,0,6 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 851069-89:
(8*8)+(7*5)+(6*1)+(5*0)+(4*6)+(3*9)+(2*8)+(1*9)=181
181 % 10 = 1
So 851069-89-1 is a valid CAS Registry Number.

851069-89-1Relevant academic research and scientific papers

Indolyl and dihydroindolyl derivatives, their manufacture and use as pharmaceutical agents

-

Page/Page column 25, (2008/06/13)

This invention relates to compounds of the formula wherein one of R6, R7 and R8 is and X, Y1 to Y4, R1 to R14 and n are as defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

Benzannelated derivatives, their manufacture and use as pharmaceutical agents

-

Page/Page column 24, (2008/06/13)

There are presented compounds of the formula wherein R6 and R7 is R4 and R5 or R5 and R6 together with the carbon atoms to which they are attached, form a ring as defined in the description

Phenyl derivatives, their manufacture and use as pharmaceutical agents

-

Page/Page column 33, (2010/02/11)

This invention relates to compounds of the formula wherein one of R5, R6 and R7 is and X1, X2, Y1 to Y4, R1 to R13 and m and n are defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 851069-89-1